- Clariant is expanding production capacity for isethionates derivatives in the USA and Spain.
- The additional capacity will be operational by Q1 2021.
- The investment includes modernization of facilities to optimize energy consumption.
- New SI grades with different carbon chains will be introduced.
Expansion of Production Capacity
Clariant is expanding its production capacity for isethionates derivatives, specifically Hostapon SCI mild surfactants, to meet the growing demand from personal care formulators and brands. This expansion will take place at their facilities in the USA and Tarragona, Spain, with additional capacity expected to be operational by Q1 2021.
Modernization and Efficiency
The investment not only targets an increase in capacity but also includes the general modernization of the current facilities. This modernization aims to optimize energy consumption and introduce new SI grades with different carbon chains, enhancing the overall efficiency and capability of the production sites.
Product Features
Hostapon SCI grades are natural, anionic mild surfactants that are plant-based, non-irritant, and ultra-mild. They comply with several industry-recognized ecolabels and are known for creating formulations with creamy, stable foams. These surfactants are part of Clariant’s extensive portfolio, which is used in skin cleansing, hair care, and baby care applications. Each product in this portfolio offers high-level cleaning performance and specific foam types or thickening behavior, supported by various formulation benefits and consumer features.
Strategic Investment
This long-term strategic investment aligns with Clariant’s recent introduction of Glucamides sugar surfactant technology. It positions the company as a leader in the development of mild surfactants, which are increasingly popular among personal care customers seeking milder and healthier solutions.
